Clinical trials
Tuberculosis, Pulmonary trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 4 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Chest Hospital | 4 |
| National University Hospital, Singapore | 4 |
| Seoul National University Hospital | 3 |
| Assiut University | 2 |
| SPP Pharmaclon Ltd. | 2 |
| Tuberculosis Clinical Diagnostics Research Consortium | 2 |
| Azienda Sanitaria-Universitaria Integrata di Udine | 1 |
| Beijing Hospital | 1 |
| Dow University of Health Sciences | 1 |
| Farman Ullah Khan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Pulmonary | 57 |
| Tuberculosis | 12 |
| Acquired Immunodeficiency Syndrome | 3 |
| COVID-19 | 2 |
| Disease | 2 |
| Latent Tuberculosis | 2 |
| Lung Neoplasms | 2 |
| Tuberculosis, Miliary | 2 |
| Tuberculosis, Multidrug-Resistant | 2 |
| Adenocarcinoma of Lung | 1 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.